Msn Laboratories Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CABOZANTINIB (S)-MALATE, with a corresponding US DMF Number 31522.
Remarkably, this DMF maintains an Active status since its submission on March 30, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 08, 2017, and payment made on May 22, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II